CJC-1295 + Ipamorelin Stack: The Complete Protocol Guide

If you've spent any time in the performance optimization or peptide therapy space, you've encountered CJC-1295 + ipamorelin. It's the most commonly prescribed growth hormone secretagogue stack — the combination used before synthetic HGH became a conversation, and still preferred by many physicians and patients who want the benefits of optimized growth hormone without the cost and suppression risks of exogenous HGH.

Understanding this stack requires understanding what growth hormone secretagogues are, how these two peptides interact, and what realistic outcomes look like for different types of users.

Growth Hormone 101

Growth hormone (GH) is secreted by the pituitary gland in pulses — primarily during deep sleep (stages 3-4), after intense exercise, and in response to fasting. It drives protein synthesis, fat oxidation, tissue repair, and IGF-1 production in the liver.

After the age of ~25, GH secretion declines by approximately 15% per decade. By 50, most people secrete roughly half the GH they did in their mid-20s. This decline contributes to: slower recovery from exercise, increased body fat (particularly visceral), reduced lean mass, impaired sleep quality, and accelerated aging of connective tissues.

Exogenous HGH directly replaces this declining output. Growth hormone secretagogues take a different approach: they stimulate your own pituitary to produce more GH. The result is an optimized version of your natural GH profile — bigger pulses, more total secretion — rather than a supraphysiologic flat line.

What Is CJC-1295?

CJC-1295 is a synthetic analog of GHRH (growth hormone-releasing hormone), the hypothalamic signal that instructs the pituitary to release GH.

Without DAC (Mod GRF 1-29): Half-life: 30 minutes. Must be dosed at time of each injection. Creates sharp, physiologic GH pulses. Preferred for most protocols.

With DAC: Drug affinity complex modification binds the peptide to albumin, extending half-life to ~7 days. Can be dosed once weekly. Creates more sustained GH elevation, but less pulsatile — which may blunt natural feedback mechanisms over time.

For the protocols in this guide, "CJC-1295" refers to the DAC-free version (Mod GRF 1-29) unless specified.

What Is Ipamorelin?

Ipamorelin is a selective GHRP (growth hormone-releasing peptide) — a ghrelin receptor agonist that stimulates GH release through a completely different pathway than CJC-1295.

Key properties: - Highly selective: stimulates GH release without significantly raising cortisol, prolactin, or ACTH (a major advantage over older GHRPs like GHRP-6 or GHRP-2) - Short half-life: ~2 hours - No meaningful effect on appetite at standard doses (unlike GHRP-6, which strongly increases hunger) - Well-tolerated: the cleanest GHRP available

Ipamorelin alone produces meaningful GH stimulation. But the real magic is in the combination.

Why the Stack Works Better Than Either Alone

CJC-1295 and ipamorelin stimulate GH release via two independent, additive mechanisms:

• CJC-1295 (GHRH analog): Acts on GHRH receptors in the pituitary, increasing GH synthesis and release
• Ipamorelin (ghrelin receptor agonist): Acts on different pituitary receptors (GHS-R1a), stimulating GH release independently

Research shows the combination produces 3-5x more GH than either peptide alone. This synergy is the defining pharmacological characteristic of the stack. You're hitting two independent signaling pathways simultaneously — the result is a substantial amplification of pituitary output.

Protocol: Standard Dosing

Beginner Protocol (1x daily) - CJC-1295 (no DAC): 100mcg - Ipamorelin: 100mcg - Timing: Before bed, after last meal (fasting state preferred — insulin suppresses GH) - Frequency: 5 days on, 2 days off (or daily — modest difference)

Intermediate Protocol (2x daily) - Morning: CJC-1295 100mcg + Ipamorelin 100mcg, fasted - Bedtime: CJC-1295 100mcg + Ipamorelin 100mcg, 2-3 hours after last meal - This produces 2 amplified GH pulses per day aligned with natural GH secretion patterns

Advanced Protocol (3x daily) - Morning (fasted), post-workout, bedtime - 100-200mcg each peptide per injection - Reserved for those with established tolerance and specific performance goals

Recommended cycle length: 3-6 months minimum for body composition benefits. Many users run longer cycles (6-12 months) with the cleaner GH profile making extended use more practical than exogenous HGH.

Administration

Both peptides are typically supplied as lyophilized powder. Reconstitute with bacteriostatic water. Inject subcutaneously (SubQ) — common sites are the abdomen, love handles, or outer thigh.

Injections are small volume — typically 0.1mL per injection. Insulin syringes (28-31g) make administration comfortable.

Critical timing rules: - Inject in a fasting state when possible — insulin and glucose blunt GH release - Avoid injecting within 1-2 hours of a large carbohydrate meal - The bedtime dose is especially effective if you haven't eaten in 2+ hours

Expected Outcomes by Timeline

2-4 weeks: - Improved sleep quality (often the first noticeable effect — deeper sleep, more vivid dreams) - Improved morning recovery - Subtle increase in well-being

4-8 weeks: - Reduced joint discomfort (GH/IGF-1 effects on connective tissue) - Improved exercise recovery - Early fat loss (particularly if combined with training)

8-16 weeks: - Measurable body composition changes - Increased lean mass (modest — these are not anabolic steroids) - Continued fat reduction - Improved skin quality, collagen synthesis

6+ months: - Cumulative benefits across all domains - Best results in users who combine with resistance training and adequate protein

Who Benefits Most

Recovery-focused athletes: The connective tissue and muscle repair effects are substantial. GH's role in satellite cell activation makes it relevant for any high-intensity training.

Body recomposition goals: The combination of modest lean mass gain + fat reduction (particularly visceral fat) is the primary use case for most non-athlete users.

Anti-aging / longevity users: Optimizing declining GH secretion is a core longevity strategy. The sleep quality improvements alone provide significant downstream benefits.

Post-injury recovery: GH secretagogues are increasingly used in rehabilitation contexts for their effects on connective tissue healing.

CJC-1295 + Ipamorelin vs. Exogenous HGH

| Factor | CJC-1295/Ipamorelin | Exogenous HGH | |--------|---------------------|---------------| | Mechanism | Stimulates natural production | Replaces natural production | | GH profile | Pulsatile (physiologic) | Flat (supraphysiologic) | | Pituitary suppression | Minimal | Significant | | Cost | $200-400/month | $600-2000+/month | | Side effects | Minimal at standard doses | More significant (edema, carpal tunnel, IGF-1 elevation) | | Results | Gradual, sustainable | Faster, more pronounced |

For most users outside competitive athletics or clinical GH deficiency, the secretagogue stack hits a compelling middle ground — meaningful results, physiologic mechanism, lower cost, minimal side effects.

The Bottom Line

CJC-1295 + ipamorelin is among the most rational peptide stacks available for performance optimization, body recomposition, and anti-aging applications. It works by amplifying your own pituitary's GH output rather than replacing it, producing a physiologic GH pulse pattern that most users find delivers excellent results with excellent tolerability.

Realistic expectations: meaningful improvements in sleep, recovery, body composition, and connective tissue health over 3-6+ months of consistent use. Not a shortcut — a protocol.